PBR Q1 2026 Earnings Earnings Miss Amid Operational Headwinds SRE Q1 2026 Earnings EPS Misses Estimates by 137 as Regulated Growth Offsets Headwinds Michael Burrys Scion Asset Management Discloses New Stake in Alibaba BABA Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances Wedbush Analyst Views Microsofts Restructured OpenAI Partnership as Net Positive Despite Market Concerns Castle Biosciences Q1 2026 Earnings EPS Beat Slightly Narrower Loss Stock Rises 26 DexCom Stock Turnaround Shows Potential Signs of Recovery